Wortelboer N, Kent S, Blommestein HM, van Ommen-Nijhof A, et al. Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial. J Natl Cancer Inst 2025 Nov 21:djaf334. doi: 10.1093.
PMID: 41270788